Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.38 billion. The enterprise value is $1.12 billion.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, before market open.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
OCUL has 159.30 million shares outstanding. The number of shares has increased by 79.29% in one year.
Current Share Class | 159.30M |
Shares Outstanding | 159.30M |
Shares Change (YoY) | +79.29% |
Shares Change (QoQ) | +0.82% |
Owned by Insiders (%) | 1.15% |
Owned by Institutions (%) | 64.53% |
Float | 122.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 24.59 |
Forward PS | 22.82 |
PB Ratio | 5.24 |
P/TBV Ratio | 5.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 18.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.22, with a Debt / Equity ratio of 0.29.
Current Ratio | 10.22 |
Quick Ratio | 9.89 |
Debt / Equity | 0.29 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -16.44 |
Financial Efficiency
Return on equity (ROE) is -57.19% and return on invested capital (ROIC) is -31.18%.
Return on Equity (ROE) | -57.19% |
Return on Assets (ROA) | -27.21% |
Return on Invested Capital (ROIC) | -31.18% |
Return on Capital Employed (ROCE) | -55.89% |
Revenue Per Employee | $217,690 |
Profits Per Employee | -$703,325 |
Employee Count | 274 |
Asset Turnover | 0.13 |
Inventory Turnover | 53.16 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +50.44% in the last 52 weeks. The beta is 1.41, so OCUL's price volatility has been higher than the market average.
Beta (5Y) | 1.41 |
52-Week Price Change | +50.44% |
50-Day Moving Average | 7.75 |
200-Day Moving Average | 8.45 |
Relative Strength Index (RSI) | 58.37 |
Average Volume (20 Days) | 2,454,643 |
Short Selling Information
The latest short interest is 14.26 million, so 8.95% of the outstanding shares have been sold short.
Short Interest | 14.26M |
Short Previous Month | 13.83M |
Short % of Shares Out | 8.95% |
Short % of Float | 11.66% |
Short Ratio (days to cover) | 8.10 |
Income Statement
In the last 12 months, OCUL had revenue of $59.65 million and -$192.71 million in losses. Loss per share was -$1.15.
Revenue | 59.65M |
Gross Profit | -95.67M |
Operating Income | -205.68M |
Pretax Income | -138.36M |
Net Income | -192.71M |
EBITDA | -201.83M |
EBIT | -205.68M |
Loss Per Share | -$1.15 |
Full Income Statement Balance Sheet
The company has $349.68 million in cash and $76.22 million in debt, giving a net cash position of $273.46 million or $1.72 per share.
Cash & Cash Equivalents | 349.68M |
Total Debt | 76.22M |
Net Cash | 273.46M |
Net Cash Per Share | $1.72 |
Equity (Book Value) | 265.93M |
Book Value Per Share | 1.67 |
Working Capital | 349.77M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$145.46 million and capital expenditures -$2.97 million, giving a free cash flow of -$148.43 million.
Operating Cash Flow | -145.46M |
Capital Expenditures | -2.97M |
Free Cash Flow | -148.43M |
FCF Per Share | -$0.93 |
Full Cash Flow Statement Margins
Gross Margin | -160.40% |
Operating Margin | -344.83% |
Pretax Margin | -323.09% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -79.29% |
Shareholder Yield | -79.29% |
Earnings Yield | -13.83% |
FCF Yield | -10.65% |
Analyst Forecast
The average price target for OCUL is $16.11, which is 86.03% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $16.11 |
Price Target Difference | 86.03% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 60.96% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 1.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.54 |
Piotroski F-Score | 1 |